Telomir Pharmaceuticals, Inc.’s Q3 2026 10-Q window runs Nov 9, 2026 to Nov 16, 2026.
Based on 8 prior 10-Q filings.
Telomir Pharmaceuticals, Inc. · CIK 1971532 · Engraved from SEC EDGAR